BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15800671)

  • 1. ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype.
    Nolz JC; Tschumper RC; Pittner BT; Darce JR; Kay NE; Jelinek DF
    Leukemia; 2005 Jun; 19(6):1018-24. PubMed ID: 15800671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes in humans express ZAP-70 when activated in vivo.
    Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
    Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
    Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
    Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia.
    Crespo M; Villamor N; Giné E; Muntañola A; Colomer D; Marafioti T; Jones M; Camós M; Campo E; Montserrat E; Bosch F
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):726-34. PubMed ID: 16467082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
    Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
    J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.
    Scielzo C; Camporeale A; Geuna M; Alessio M; Poggi A; Zocchi MR; Chilosi M; Caligaris-Cappio F; Ghia P
    Leukemia; 2006 Apr; 20(4):689-95. PubMed ID: 16482211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells.
    Guillaume N; Alleaume C; Munfus D; Capiod JC; Touati G; Pautard B; Desablens B; Lefrère JJ; Gouilleux F; Lassoued K; Gouilleux-Gruart V
    Haematologica; 2005 Jul; 90(7):899-905. PubMed ID: 15996927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
    Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
    Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
    Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
    Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
    Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
    Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL/SLL.
    Sup SJ; Domiati-Saad R; Kelley TW; Steinle R; Zhao X; Hsi ED
    Am J Clin Pathol; 2004 Oct; 122(4):582-7. PubMed ID: 15487457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia.
    Wandroo F; Bell A; Darbyshire P; Pratt G; Stankovic T; Gordon J; Lawson S; Moss P
    Int J Lab Hematol; 2008 Apr; 30(2):149-57. PubMed ID: 18333847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T cell receptor zeta/ZAP-70-dependent and -independent signaling pathways in T cells.
    Deckert M; Ticchioni M; Mari B; Mary D; Bernard A
    Eur J Immunol; 1995 Jul; 25(7):1815-22. PubMed ID: 7542590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.